Francisco Pazos - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Francisco Pazos's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Francisco Pazos

Francisco Pazos

Verified

Digital Producer, TelevisaUnivision

Final Covers

políticosSociales culturales

Doesn’t Cover

Insurance, crime, death (with occasional exceptions).

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

Content

Total articles 67

  • Efectividad de la vacuna CanSino es de 96 % contra Covid-19 grave

    By Francisco Pazos Verified| tecreview.tec.mx@ La efectividad de la vacuna CanSino es de 96 % contra la enfermedad grave de Covid-19, confirmaron los resultados de los estudios clínicos de Fase 3, hechos públicos este 23 de diciembre. El laboratorio CanSino Biologics Inc. publicó los resultados de Fase 3 de la Vacuna Recombinante Novel Coronavirus (Convidecia) en la revista especializada The Lancet.

    By Francisco Pazos Verified · tecreview.tec.mx

    Dec. 26, 2021

  • La cuarta ola en México y los rebrotes que amenazan en Europa

    By Francisco Pazos Verified| tecreview.tec.mx@ La apertura de actividades comerciales y la organización de eventos masivos abre la duda sobre si es posible una cuarta ola en México de Covid-19. Aunque la vacunación alcanza a por lo menos 84 % de los adultos mayores de 18 años y los casos de contagios, muertes y hospitalizaciones rozan sus cifras más bajas, el riesgo de una cuarta ola en México es real.

    By Francisco Pazos Verified · tecreview.tec.mx

    Nov. 11, 2021

  • Efectividad de la vacuna CanSino es de 96 % contra Covid-19 grave

    By Francisco Pazos Verified| tecreview.tec.mx@ La efectividad de la vacuna CanSino es de 96 % contra la enfermedad grave de Covid-19, confirmaron los resultados de los estudios clínicos de Fase 3, hechos públicos este 23 de diciembre. El laboratorio CanSino Biologics Inc. publicó los resultados de Fase 3 de la Vacuna Recombinante Novel Coronavirus (Convidecia) en la revista especializada The Lancet.

    By Francisco Pazos Verified · tecreview.tec.mx

    Dec. 26, 2021

As seen in

Company Info

TelevisaUnivision

TelevisaUnivision is a prominent Mexican-American media conglomerate focused on producing and distributing Spanish-language content. With headquarters in Miami, Florida, and Mexico City, it plays a significant role in Hispanic media, catering to audiences in the U.S. and Mexico. The company was formed through a merger in 2022, building on its history that dates back to 1962 as the Spanish International Network. The company operates several broadcast networks, including Univision, the leading Spanish-language network in the U.S., and various channels in Mexico such as Las Estrellas and Canal 5. It also offers ViX, the largest Spanish-language streaming platform, featuring original series, movies, and live sports. Additionally, TelevisaUnivision has a strong presence in audio with Uforia, a network of radio stations, and TUDN, which focuses on sports programming. With around 14,000 employees, the company is dedicated to serving Hispanic and Latino audiences through a diverse range of media platforms.

Miami, Florida, United States

Founded: 2022